| ATPC 0.1085 55.00% | MTEN 0.0341 -3.40% | OCG 0.01 -15.25% | SOXS 2.1449 -5.93% | AUID 1.87 88.41% | ZSL 2.9224 3.82% | CJMB 3.8899 247.31% | IVP 0.049 -40.24% | NVDA 187.1718 2.20% | SLV 83.375 -1.40% | ASST 0.9713 -5.70% | BBAI 6.285 0.40% | INTC 48.6734 -0.10% | SPHL 23.245 933.11% | DVLT 0.7323 1.96% | TZA 5.965 -3.17% | ONDS 13 -4.13% | GRAB 4.355 -5.94% | TQQQ 54.3 0.87% | BYND 1.0151 5.53% | SOXL 58.99 6.52% | BNKK 4.1 47.48% | NVD 7.095 -4.25% | DNN 3.545 1.72% | APLT 0.1003 0.40% | PTHL 0.8008 82.08% | PLUG 2.275 -3.19% | IBRX 3.9107 29.49% | DUST 5.755 -0.69% | AAL 15.68 3.57% | BITO 13.2128 -2.56% | SPY 691.71002 0.20% | TSLS 5.205 0.29% | TSLL 17.9686 -0.56% | EEM 58.0992 0.60% | MSTX 4.8291 -7.13% | FNGD 5.54 0.54% | ACHR 8.9322 0.25% | AMD 228.895 2.37% | QQQ 621.40302 0.30% | SIDU 3.72 -0.80% | IBIT 54.0499 -2.51% | NOK 6.615 4.01% | JDST 2.0837 -1.01% | TSLA 438.17001 -0.23% | RZLV 4.6464 14.44% | GPUS 0.2815 -12.28% | SOFI 26.35 -1.20% | MARA 10.7746 -3.02% | XLE 47.67 -0.81%

BofA Downgrades Cadre Holdings To Underperform, Cuts Price Target

BofA Securities downgraded Cadre Holdings (NYSE:CDRE) to Underperform from Neutral and lowered its price target to $26.00 from $38.00.

The analysts noted that concerns highlighted in a prior downgrade — including slow growth and a challenging M&A environment — have persisted. Since reporting second-quarter results, the firm pointed to the potential for additional pressure on organic growth in the second half of 2025, citing a 1% decline in Q2 and management’s comments on contract delays.

Investor sentiment appeared to reflect these concerns, with Cadre’s shares falling about 16% on August 6, while the S&P 500 rose roughly 1%. The new price target of $26 is based on a relative EV/EBITDA multiple for 2026 estimates, which remains unchanged.

Published on: August 13, 2025